sorafenib has been researched along with Erythema Multiforme in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggarwal, D; Daroach, M; Guliani, A; Kumaran, MS; Radotra, BD | 1 |
| Andoh, A; Bamba, S; Fujiyama, Y; Inatomi, O; Nishida, A; Nishimura, T; Sasaki, M; Shioya, M | 1 |
| Cardones, AR; Chu, EY; Dahut, WL; Kong, HH; Pichard, DC | 1 |
| Feito Rodríguez, M; Feltes, RA; González-Beato, MJ | 1 |
| Bilaç, C; Ermertcan, AT; Kayhan, TC; Müezzinoğlu, T; Oztürkcan, S; Temeltaş, G; Temiz, P | 1 |
| Fukui, I; Hatake, K; Kodaira, M; Saotome, T; Takahashi, S; Takeuchi, K; Yonese, J; Yuasa, T | 1 |
| Farley-Loftus, R; Lewin, J; Pomeranz, MK | 1 |
| Fujita, T; Ikeda, M; Iwamura, M; Matsumoto, K; Mii, S; Satoh, T; Tabata, K; Tanabe, K | 1 |
| Grossman, ME; MacGregor, JL; Sherman, WH; Silvers, DN | 1 |
9 other study(ies) available for sorafenib and Erythema Multiforme
| Article | Year |
|---|---|
Severe hand-foot skin reaction and erythema multiforme-like lesions due to sorafenib.
Topics: Antineoplastic Agents; Biopsy; Drug Eruptions; Erythema Multiforme; Female; Foot; Hand; Humans; Middle Aged; Sorafenib | 2018 |
[Two cases of successful sorafenib retreatment with the addition of steroid therapy following sorafenib-induced erythema multiforme in two patients with hepatocellular carcinoma].
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Erythema Multiforme; Female; Humans; Liver Neoplasms; Male; Niacinamide; Phenylurea Compounds; Prednisolone; Sorafenib | 2014 |
Sorafenib-Induced Eruption Mimicking Erythema Multiforme.
Topics: Aged; Antineoplastic Agents; Drug Eruptions; Erythema Multiforme; Humans; Male; Niacinamide; Phenylurea Compounds; Sorafenib | 2016 |
Erythema multiforme induced by sorafenib.
Topics: Adult; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Drug Eruptions; Erythema Multiforme; Female; Humans; Kidney Neoplasms; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib | 2009 |
Sorafenib-induced erythema multiforme in metastatic renal cell carcinoma.
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Dose-Response Relationship, Drug; Erythema Multiforme; Humans; Kidney Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Treatment Outcome | 2009 |
Sorafenib-induced erythema multiforme for metastatic renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Erythema Multiforme; Female; Humans; Kidney Neoplasms; Male; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Treatment Outcome | 2010 |
Erythema multiforme-like drug reaction to sorafenib.
Topics: Adult; Benzenesulfonates; Diagnosis, Differential; Drug Eruptions; Erythema Multiforme; Female; Hand Dermatoses; Humans; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Sorafenib | 2011 |
Erythema multiforme induced by sorafenib for metastatic renal cell carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Disease-Free Survival; Erythema Multiforme; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Nephrectomy; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Retrospective Studies; Sample Size; Sorafenib; Treatment Outcome | 2012 |
Sorafenib-induced erythema multiforme.
Topics: Administration, Oral; Benzenesulfonates; Erythema Multiforme; Female; Humans; Lung Neoplasms; Melanoma, Amelanotic; Middle Aged; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Sorafenib | 2007 |